captur bump
enough chang stori
modest benefit greater benefit
updat model walgreen ahead earn releas april
anticip us outbreak drive modest benefit
februari end substanti benefit form higher front
store sale demand medic suppli well run household item
lesser extent increment script uplift given waiv refil time limit due
outbreak overal remain difficult assess exactli long benefit
persist though note walgreen one compani directli benefit
think see nt upsid lack long-term
optim keep us under-perform rate price object ep
rais store front store sale estim
increas retail front store store sale estim
reflect recent increas demand toiletri
person protect suppli like glove hand sanit etc increas
adjust ep ep
driven factor somewhat off-set wage invest
announc compani would note estim still assum share
repurchas remov would headwind remaind
topic call asid guide/buyback
question call includ size nt benefit directli relat
embed guidanc prior thought full year ep
guidanc may difficult achiev import disaggreg driver
retail pharmaci highlight retail way patient access earli rx
suppli back-up purpos impact program focu addit
introduc free rx ship free deliveri could impact
remaind year separ help off-set weak
european busi focu beyond still look walgreen
articul long-term strateg plan support core oper earn growth
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
pressur competit dynam
potenti increment competit
amazon small step market core
profit dollar growth slow think limit
visibl creat challeng near-term
stock perform view range-bound
exhibit survey suggest limit expect avoid prescript given outbreak
given presenc coronaviru diseas like would
avoid fill prescript
somewhat like
like defer
exhibit servic at-hom deliveri local store central fill pharmaci
given presenc coronaviru diseas like would
avoid fill prescript
like use mail order
like go
survey detail pleas see survey analyz procedur
concern like delay
exhibit earli trade middl peer group ntm price-to-earnings basi share trade bottom end
exhibit entir comp group impact sell-off although retail meaning outperform
exhibit wba recent histori mid-year guidanc revis although benefit help
compani file factset bofa global research
price object base ep multipl
five-year averag absolut basi around discount five-year
averag reflect view walgreen core retail pharmaci busi long-
term structur pressur must diversifi stabl busi line improv
upsid risk better expect gener save new partnership
healthcar area labcorp etc support long-
term growth addit volum econdisc/rit aid contribut
addit new partnership faster expect growth prime therapeut
relationship downsid risk po on-going price reimburs pressur
higher prescript attrit part relationship integr risk
risk amazon anoth disrupt forc enter suppli chain market lack
available/app attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
